
CARDIAC tests for the Cobas H232 are precise point-of-care diagnostic tests designed for the rapid and reliable detection of cardiovascular diseases and thromboembolic events. With a broad selection of test parameters – from troponin T, CK-MB, and myoglobin to D-dimer and ProBNP+ – they enable rapid decision-making directly at the patient's bedside or in the doctor's office. The tests are specifically designed for the Cobas H232 analyzer and deliver results within minutes.
Areas of application:
-
Early diagnosis of acute myocardial infarction (AMI)
-
Detection of myocardial damage and acute coronary syndrome
-
Exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE)
-
Support in the diagnosis and monitoring of heart failure
-
Risk stratification in patients with acute coronary syndrome
-
Monitoring of the course of compensated left ventricular dysfunction
Advantages at a glance:
-
Fast results at the point of care
-
High diagnostic accuracy
-
Broad range of tests for cardiovascular and thromboembolic diseases
-
Minimum sample volume from venous whole blood (EDTA or heparin)
-
Compatible with the Cobas H232 analyzer
-
Optimized for fast clinical decisions
Further information:
-
Qualitative detection of troponin, CK-MB, myoglobin, D-dimer and proBNP+
-
Results in a few minutes, depending on the test parameters
-
Easy handling for medical professionals
Delivery information: 20 tests
PZN: " 07029231 "
WEEE number:
Assistive device number:
Manufacturer:
Roche Deutschland Holding GmbH
Emil-Barell-Str. 1
79639 Grenzach-Wyhlen
Deutschland
Tel: +49 7624 14 – 0
Email: grenzach.communications@roche.com
VAT ID number: DE197246205